|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | |
| C12Q 1/68 |
| (11) | Patento numeris | 2416779 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10712676.5 |
| Europos patento paraiškos padavimo data | 2010-04-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-02-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-03-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/029945 |
| Data | 2010-04-05 |
| (87) | Numeris | WO 2010/117943 |
| Data | 2010-10-14 |
| (30) | Numeris | Data | Šalis |
| 167140 P | 2009-04-06 | US |
| (72) |
LAVEDAN, Christian, US
VOLPI, Simona, US
LICAMELE, Louis, US
|
| (73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037,
US
|
| (54) | METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION BASED ON BAI3 GENE SEQUENCE OR PRODUCT THEREOF |
| METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION BASED ON BAI3 GENE SEQUENCE OR PRODUCT THEREOF |